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Disruption of maternal gut microbiota
during gestation alters offspring microbiota
and immunity
Donald D. Nyangahu1,8, Katie S. Lennard2, Bryan P. Brown3,8, Matthew G. Darby1, Jerome M. Wendoh1,
Enock Havyarimana1, Peter Smith1, James Butcher4, Alain Stintzi4, Nicola Mulder2, William Horsnell1,5,6†
and Heather B. Jaspan1,7*†
Abstract
Background: Early life microbiota is an important determinant of immune and metabolic development and may
have lasting consequences. The maternal gut microbiota during pregnancy or breastfeeding is important for
defining infant gut microbiota. We hypothesized that maternal gut microbiota during pregnancy and breastfeeding
is a critical determinant of infant immunity. To test this, pregnant BALB/c dams were fed vancomycin for 5 days prior
to delivery (gestation; Mg), 14 days postpartum during nursing (Mn), or during gestation and nursing (Mgn), or no
vancomycin (Mc). We analyzed adaptive immunity and gut microbiota in dams and pups at various times after delivery.
Results: In addition to direct alterations to maternal gut microbial composition, pup gut microbiota displayed lower
α-diversity and distinct community clusters according to timing of maternal vancomycin. Vancomycin was
undetectable in maternal and offspring sera, therefore the observed changes in the microbiota of stomach contents
(as a proxy for breastmilk) and pup gut signify an indirect mechanism through which maternal intestinal microbiota
influences extra-intestinal and neonatal commensal colonization. These effects on microbiota influenced both maternal
and offspring immunity. Maternal immunity was altered, as demonstrated by significantly higher levels of both total
IgG and IgM in Mgn and Mn breastmilk when compared to Mc. In pups, lymphocyte numbers in the spleens of Pg and
Pn were significantly increased compared to Pc. This increase in cellularity was in part attributable to elevated numbers
of both CD4+ T cells and B cells, most notable Follicular B cells.
Conclusion: Our results indicate that perturbations to maternal gut microbiota dictate neonatal adaptive immunity.
Background
The gut microbiota during a critical window in infancy is
key for immune development, establishment of oral toler-
ance, and mucosal barrier function [1]. The fetal gut has
long been assumed to be sterile, with colonization occur-
ring only at delivery [2]. Although controversial, this dogma
has recently been challenged with the apparent identifica-
tion of low abundance bacteria in fetal membranes,
amniotic fluid, and placenta [3–8]. Regardless, maternal
diet before and during pregnancy has been shown to influ-
ence offspring metabolism, as well as susceptibility to al-
lergy and bacterial infections [9–11]. Postpartum, maternal
factors continue to be important determinants of early in-
fant colonization [2], including type of infant feeding [12].
Both breast milk bacterial composition [13] and human
milk oligosaccharides (HMOs) are thought to influence in-
fant gut microbiota. Breast milk has its own microbiota,
the origins of which are not completely understood, but are
believed to be partly due to translocation from the gut [14].
Antibiotics, although necessary in some cases, can lead
to disruption of the commensal bacteria with lasting con-
sequences [15, 16]. Maternal antibiotics during lactation
have lasting metabolic and immunological consequences
on offspring mediated presumably via alteration of the
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neonatal microbiome [17–20]. In germ-free mice, transient
colonization of maternal intestines with E. coli during gesta-
tion causes intestinal innate immune alterations in the off-
spring, yet does not influence pup adaptive immunity [21].
Here, using oral vancomycin, which has low oral bioavailabil-
ity, we show that alteration of maternal gut microbiome dur-
ing gestation, nursing, or both has persistent effects on
offspring gut microbiota and systemic adaptive immunity.
Results
Maternal gut microbiota during gestation and nursing
differentially shape infant mouse intestinal microbiota
To assess the impact of maternal gut microbiota during
fetal development and nursing on infant microbiota, we
treated pregnant dams with oral vancomycin for 5 days
prior to delivery (gestation: Mg), for 14 days postpartum
during nursing (nursing: Mn), or both (gestation and
nursing: Mgn) and compared these to control dams
(Mc) (Fig. 1a). We analyzed intestinal microbiota by
sequencing the V6 region of the 16S rRNA gene of bacterial
DNA from intracolonic fecal pellets obtained 14 days post-
partum. Maternal oral vancomycin had distinct effects on
maternal gut microbiota at 14 days postpartum, depending
on the timing of treatment. Gut microbiota α-diversity was
decreased in vancomycin-treated mothers compared to con-
trols (Additional file 1: Figure S1A). Principal coordinate
analysis (PCoA) of β-diversity (by Bray-Curtis dissimilarity)
demonstrated that all antibiotic-treated dams clustered sep-
arately from Mc, although Mgn and Mn clustered together
(Additional file 1: Figure S1B). Pup intestinal microbiota at
14 days postpartum also showed distinct changes associated
with maternal vancomycin treatment. We observed signifi-
cantly reduced α-diversity, in pups born to dams treated
with vancomycin during nursing (Pn) or gestation plus
nursing (Pgn) compared to pups born to control dams (Pc)
(Fig. 1b). Further, PCoA analysis of β-diversity by Bray-Curtis
dissimilarity demonstrated the existence of distinct microbial
communities dependent on the timing of maternal exposure
to vancomycin (Fig. 1c; Adonis R2 = 0.449, p= 0.001). Pg had
microbiomes distinct from all other groups, suggesting that
disruption of maternal gut microbiota with vancomycin
during gestation only alters offspring microbiota differently
as compared to vancomycin treatment during breastfeeding.
In a PCoA including both maternal and pup microbiota, pup
communities clustered closest to their own mothers’ com-
munities (Additional file 1: Figure S1D).
As expected, at the Phylum level, stool of
vancomycin-treated dams had higher relative abun-
dance of Proteobacteria versus Mc (Additional file 1:
Figure S1C). However, the relative abundance of the
phylum Bacteroidetes (also gram negative) was decreased in
all antibiotic-treated dams compared to Mc. This was also
evident in pups from antibiotic-treated dams who displayed
significantly reduced relative abundance of Bacteroidetes in
their colonic contents as compared to control pups (adj p <
0.001 vs Pc for all intervention groups). In addition, Proteo-
bacteria was significantly increased in pups born to
vancomycin-treated dams regardless of timing compared to
control pups (adj p < 0.001 vs Pc for all intervention groups
Fig. 1d). Next, using both Deseq2 and metagenomeSeq, we
identified several significantly differentially abundant taxa
across the groups after merging at the lowest taxonomic
annotation. Bacteroides acidifaciens, Bacteroides ovatus,
Ruminococcus gnavus, and Parabacteroides distasonis
were significantly less abundant in all intervention groups
compared to Pc (adj p < 0.001 vs Pc for all except Pc vs Pg
B ovatus p < 0.05), Fig. 1e). Additionally, Corynebacterium
mastitidis was significantly increased in Pg compared to
Pc but was undetectable in Pn. Moreover, Enterococcus
casseliflavus was undetectable in Pg and Pn. Overall, these
data suggest that maternal gut microbiota influence pup
gut microbiota.
Maternal gut microbiota impacts breastmilk and genital
tract microbiota
Since vancomycin has poor oral bioavailability and
would therefore not be expected to directly impact off-
spring microbiota, we investigated the potential indirect
mechanisms through which maternal treatment could
alter offspring microbiota. We first confirmed that
vancomycin was indeed not absorbed by the dams nor
indirectly being taken up by the pups, by measuring
vancomycin levels in serum 2 days postpartum for Mg
dams or 14 days in Mn/Mgn dams and Pg/Pn/Pgn pups.
Vancomycin was below the detectable level of 3 μg/mL
in all maternal and offspring plasma (Additional file 1:
Table S1), although we cannot rule out the possibility
that trace vancomycin levels below the detectable level
were present. As delivery may be a determinant of off-
spring microbiota, and that vaginal microbiota influence
infant microbiota during vaginal delivery [22, 23], we
tested whether maternal gut microbiota may be influen-
cing vaginal microbiota. Dams were treated with vanco-
mycin for 5 days prior to delivery or left untreated
(Fig. 2a). Four days postpartum, dams were sacrificed
and genital tract tissue harvested. Although the Shannon
index was lower in Mg, this difference was not significant
(p = 0.066, Fig. 2b). There was also weak clustering of
β-diversity in a PCoA analysis (Adonis R2 = 0.27, p = 0.085,
Additional file 1: Figure S2A); however, the sample size was
small and due to the fact that vaginal microbiota were only
investigated at 4 days postpartum, we cannot rule out that
differences in vaginal microbiota at delivery did not exist.
Considering the importance of breastfeeding in infant
gut colonization, we next analyzed breastmilk microbiota.
Given the technical challenges of collecting sufficient
breastmilk for microbiota profiling directly from nursing
dams, we instead sampled the pup stomach contents
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Fig. 1 Maternal oral vancomycin profoundly alters pup intestinal microbiota composition. a Experimental setup: BALB/C mice received oral vancomycin
(1 mg/mL) for 5 days prior to delivery (gestation: Mg), 14 days after delivery (nursing: Mn), or 5 days prior to delivery through 14 days of nursing (gestation
plus nursing: Mgn). Control mice (Mc) were not exposed to vancomycin. Fecal samples were collected from both mothers and their offspring 14 days
postpartum. b Shannon index of pup fecal microbiotas of pups born to control (Pc: brown), Mgn (Pgn: blue), Mg (Pg: gray), or Mn (Pn: yellow) dams.
Boxplot shows 25th and 75th percentiles with a line at the median. c Principal coordinate analysis of pups’ fecal microbial β-diversity based on Bray-Curtis
dissimilarity. d Significantly different taxa abundances at phylum level in pup fecal microbiota communities after centered log ratio data transformation
(Kruskal-Wallis and Mann Whitney U test). e Significantly differentially abundant OTUs in pup fecal microbiota obtained from both MetagenomeSeq and
Deseq2 analyses performed on data merged at the lowest taxonomic level. B. ovatus: Bacteroides ovatus, P. distasonis: Parabacteroides distasonis, B.
acidifaciens: Bacteroides acidifaciens, C. mastitidis: Corynebacterium mastitidis, R. gnavus: Ruminococcus gnavus, E. casseliflavus: Enterococcus casseliflavus.
Results were combined from two independent experiments. n= 6–10 pups per group per experiment. *p< 0.05, **p< 0.01, ***p< 0.001
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shortly after feeding as a proxy for the murine breastmilk.
Vancomycin alteration of maternal gut microbiota resulted
in significant changes in microbiota of stomach contents. In
stomach contents collected at day 4 postpartum (as in
Fig. 2a), significant vancomycin-dependent effects on both
α- (p = 0.015) and β-diversity (Adonis R2 = 0.489, p =
0.016) were found (Fig. 2c, d). To assess the long-term
effect of gestational maternal antibiotics as well as
Fig. 2 Maternal gut microbiota indirectly impacts genital tract and breastmilk microbiota. a Experimental setup: BALB/c mice were treated with
vancomycin 5 days prior to delivery (Mg) or left untreated (Mc). Four days after delivery, mice were sacrificed and genital tract samples collected for 16S
rRNA gene analysis. Stomach contents were also collected from pups’ stomach for microbiome analysis. b Shannon index of Mg (blue) versus Mc (red)
genital tract microbiota. c Shannon index of stomach contents microbiota (collected from pups’ stomach 4 days after delivery). d Principal coordinate
analysis of stomach contents microbiota day 4 postpartum by Bray-Curtis dissimilarity. e Shannon index of stomach contents microbiota collected from
pups’ stomachs 14 days after delivery. f Principal coordinate analysis of stomach contents microbiota by Bray-Curtis dissimilarity collected 14 days after
delivery. g Bayesian estimates of the proportion of microbes in pup stool that came from the mother. Error bars represent standard error of the mean
(SEM). Data representative of two independent experiments. n= 4–6 breastmilk/2 genital tract samples per group per experiment. *p< 0.05
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antibiotics during breastfeeding on breastmilk microbiota,
stomach contents were also sampled from pups’ stomachs at
day 14 postpartum (as in Fig. 1a). Here, the largest effect on
both α- and β-diversity was seen in stomach contents of
pups whose mothers were treated with antibiotics during
nursing (Pn and Pgn; Fig. 2e). However, Pg stomach contents
also showed distinct clustering from Pc (Fig. 2f).
To investigate the contribution of maternal gut and
breastmilk microbiota on the establishment of pup stool
microbiota, we used SourceTracker, a tool which directly
estimates source proportions and uses Bayesian modeling
of uncertainty about known and unknown source environ-
ments [24]. In all pups, maternal gut and stomach content
microbiota had an influence on gut microbiota (Fig. 2g
and Additional file 1: Figure S2B). Many of the taxa
present in the Pc and Pg microbiota were from unknown
sources, suggesting other sources such as skin, vaginal, or
environmental microbiota have a large influence on pup
microbiota. In summary, the maternal gut microbiota
likely influences stomach content (as a proxy for breast-
milk) and vaginal microbial composition, and together
these influence bacterial colonization of the infant gut.
Maternal gut microbiota influences inherent adaptive
immunity in offspring
We next assessed whether the alterations in infant gut
microbiota had consequences on lymphocyte profiles in
pups. Pups born to dams treated with vancomycin had
significantly higher total cell counts in the spleen compared
to controls (Fig. 3a). Although no differences in proportion
of CD3+ cells that were CD4+ were notable (Fig. 3b), there
were significantly higher numbers of CD4+ T cells present
in Pg compared to the other groups (Fig. 3c). The propor-
tions and numbers of effector memory CD4+ T cells
(CD44hiCD62Llo) and central memory CD4+ T cells
(CD44hiCD62Lhi) in offspring born to mothers treated with
vancomycin were similar regardless of treatment (Fig. 3e, f).
B cell frequencies and counts were also altered in pups of
maternal vancomycin-treated groups (Fig. 4). Although
there were no differences in proportions of CD19+B220+
cells in intervention groups versus Pc (Fig. 4a), Pg exhibited
significantly increased numbers of CD19+B220+ cells com-
pared with Pc (p = 0.020, Fig. 4b). In the follicular (FO) B
cell compartment, frequency of FO cells within the B cells
were significantly reduced in Pgn and Pn (p = 0.017 and
0.002 respectively) (Fig. 4d), and FO cell numbers were in-
creased in Pg (p = 0.020). Pgn had reduced marginal zone
(MZ) B cell frequency compared to controls (p = 0.002),
whereas Pg had increased MZ B cell numbers (p = 0.022;
Fig. 4g). Total IgG and IgM were significantly higher in
stomach contents of Pgn and Pn versus Pc, implying that
maternal humoral immunity may be altered in their
mothers (Fig. 4h, i). To address the possibility that changes
in splenic populations were due to inflammation, we
Fig. 3 Maternal oral vancomycin impacts spleen cellularity at 14 days postpartum. Pups born to vancomycin breeders were sacrificed 14 days postpartum
and their spleen lymphocyte populations characterized by FACS. a Total spleen cell counts of Pc (brown), Pgn (blue), Pg (gray), and Pn (yellow). b
Proportions and c numbers of CD3+ cells that are CD4+. d Representative flow plot of effector and central memory CD4+ T cell subsets in spleen of Pc
versus Pgn, gated from CD4+ population. Frequency of CD3+CD4+ that are e CD44hiCD62Lhi (central memory CD4 T cells) and f CD44hiCD62Llo (effector
memory CD4 T cells). Graphs shown as mean ± SEM. Data are representative of two independent experiments. n = 6–10 pups per group.
*p < 0.05, **p < 0.01, ***p < 0.001. Kruskal-Wallis test followed by Mann-Whitney U test
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measured the concentration of lipocalin-2 in serum.
Lipocalin-2 has previously been described as a marker of
gut inflammation [25]. We observed no difference in the
concentration of serum lipocalin-2 across all pup groups
(Fig. 4j) suggesting that changes in immunity were likely
due to changes in microbiota and not as a result of systemic
inflammation. Together, these data show that
vancomycin-treatment induced changes in maternal gut
microbiota associated with a significant change in
breastmilk-derived antibodies as well as the profile of
splenic lymphocyte populations in offspring.
Discussion
It is established that maternal health influences offspring
gut microbial colonization [26]. However, to date, few
studies have investigated the effects of maternal gut
microbiota during gestation on offspring immunity. In
this study, we show that antibiotic alteration of maternal
gut microbiota during pregnancy and/or nursing results
in changes in systemic adaptive immunity in offspring.
Pup intestinal microbiota was significantly impacted
by maternal vancomycin treatment, regardless of timing
of intervention. No vancomycin was detectable in the
serum of treated dams, suggesting that any changes in
maternal microbiota at other mucosal sites, as well as in
pup microbiota, were due to indirect effects of altered
maternal gut microbiota and not due to direct exposure
to the antibiotic. However, we cannot rule out the possi-
bility that trace amounts of vancomycin were absorbed
and directly altered the offspring microbiota. Timing
Fig. 4 Maternal oral vancomycin impacts infant and maternal B cell compartments. Pups born to vancomycin breeders were sacrificed 14 days
postpartum and their inherent spleen immunity characterized by FACS. Total IgM and IgG was measured in offspring sera and maternal breastmilk
14 days postpartum. a, b Proportion and absolute counts for total B cells. c Representative flow plot of Marginal and Follicular B cell subsets in spleen
of Pc versus Pn. d, e Frequencies and numbers of Follicular B cells in infant spleen. f, g Frequencies and numbers of Marginal zone B cells in infant
spleen. f Total IgM in infant serum 14 days postpartum. h, i Total IgM and IgG respectively in maternal breastmilk (collected from pup’s stomach),
14 days postpartum. j Serum levels of lipocalin-2 in pup serum at 14 days postpartum. Graphs shown as mean ± SEM. Data are representative of two
independent experiments. n = 6–10 pups per groups. *p < 0.05, **p < 0.01, ***p < 0.001. Kruskal-Wallis test followed by Mann-Whitney U test
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resulted in unique effects on infant gut microbiota. Even
when administered during gestation only, alterations in ma-
ternal gut microbial communities were evident 14 days post-
partum, which were unique and clustered distinctly when
compared to control- and nursing-treated dams. Further-
more, maternal gut microbial alterations during gestation
affected pup stomach content (as a proxy for breastmilk)
microbiota and to a lesser degree, vaginal microbiota. Micro-
bial crosstalk between mucosal sites has been suggested to
occur between surfaces such as the mouth and placenta [27],
and microbial translocation from the gut to distal sites has
recently been described [28].
Although breastmilk contains oligosaccharides and
other prebiotics, breastmilk microbiota can influence in-
fant gut microbiota [13]. In humans, short-chain fatty
acids (SCFA), which have been implicated in immunity
[29], are produced following the bacterial fermentation
of human milk oligosaccharides (HMOs) that are found
in breastmilk. It is possible that alterations in mouse
breastmilk microbial profiles may alter the metabolite
profiles in their milk, hence indirectly influencing
colonization patterns in offspring. Our findings of in-
creased total immunoglobulin G and M in stomach con-
tents of dams who received vancomycin during nursing
are interesting and consistent with a mouse model of C.
difficile infection where vancomycin treatment was asso-
ciated with lower IgA and IgG levels in sera [30]. How-
ever, these findings raise another possible mechanism
through which alterations in maternal gut microbiota
may influence that of the pup gut. Vancomycin-induced
changes in maternal antibodies may mediate altered pup
microbiota by changing the opsonized fraction of breast-
milk bacteria, in addition to changing the breastmilk
microbiota itself. However, since others have shown that
the IgG bound fraction of breastmilk microbiota is simi-
lar to the non-bound fraction [31], this second mechan-
ism is less likely.
Inherent immunity was altered in pups born to
vancomycin-treated dams. B cells, particularly FO B
cells, were significantly reduced in Pn and Pgn and in-
creased in Pg compared to controls. These data add to
the recent findings reported by Gomez and colleagues
who showed no impact of maternal microbiota during
pregnancy on infant T cell activation status in the bone
marrow and other systemic sites [21]. However, this
study utilized a germ-free maternal-neonatal model
where mothers were transiently mono-colonized during
gestation, an effect that was short-lived. By the time of
delivery, both the maternal birth canal and the neonates
were germ free. Although we did not assess long-term
effects of these changes in our model, others have found
long-term consequences of antibiotic-perturbed mater-
nal microbiota on offspring susceptibility to colitis [32].
The data we present here clearly shows that an altered
maternal microbiota can strikingly influence offspring
adaptive immunity.
Taxonomic changes caused by maternal treatment were
the likely drivers of immune outcomes in pups. A reduced
relative abundance of R. gnavus or B. ovatus in Pgn and Pn
could be a potential cause of reduced frequencies of FO B
cells in these pups compared to controls. Therefore, it is
plausible that these organisms could be exploited in future
experiments to augment follicular B cell development.
Alternatively, since gut microbial-derived SCFAs are im-
portant regulators of the B cell compartment and systemic
immunoglobulin levels [33], these could be explored as po-
tential immune modulators during development.
Conclusion
In conclusion, our data provide insight into the mechan-
ism through which maternal exposures during pregnancy
are important determinants of the health of her infant.
We further identify alteration of breastmilk (stomach con-
tent) microbiota as a partial intermediary between the in-
fant and maternal gut microbiota. These findings are
important since the maternal gut microbiota is potentially
modifiable and therefore may be manipulated in interven-
tions to improve infant health.
Methods
Experimental design
Female 6–8-week-old BALB/c mice were mated by housing
two females and an adult male per cage for 7 days, after
which the male was removed. Dams were treated orally
with vancomycin (1 mg/mL) in drinking water 5 days prior
to giving birth (gestation group), 14 days after delivery
(nursing group), or 5 days prior to delivery and throughout
nursing (gestation plus nursing group). Vancomycin was
not administered to the control dams. We investigated the
effect of oral vancomycin when administered at various
phases on offspring growth, immunity, and gut micro-
biome. Pups were sacrificed 4 or 14 days after birth and
sampled for feces (individually from colons) and breastmilk
(stomach contents) for microbiome analysis and spleens for
immune analysis. In dams, genital tract samples were
collected 4 days after delivery for microbiome analysis.
Sample preparations and DNA extractions
Fecal samples were collected from colons at sacrifice and
stored at − 20 °C. For bacterial DNA extractions, we in-
cluded an additional enzymatic lysis procedure [34] before
using the Powersoil Isolation Kit (Mo Bio Laboratories).
Briefly, 50 μL lysozyme (10 mg/mL, Sigma-Aldrich), 6 μL
mutanolysin (25 KU/mL, Sigma-Aldrich), and 3 μL lysosta-
phin (4000 U/mL, Sigma-Aldrich) were added to 100 μL
aliquot of cell suspension followed by incubation for 1 h at
37 °C. The lysate was then subjected to further DNA isola-
tion and purification using the Powersoil DNA Isolation Kit
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(Mo Bio Laboratories) as per the manufacturer’s instruc-
tions. The final DNA concentration was determined by the
Quanti-It Picogreen dsDNA HS assay kit (Invitrogen, UK).
16S rRNA gene sequencing
16S rRNA gene sequencing was performed using the ex-
tracted metagenomic DNA as previously described [35, 36].
Briefly, the hypervariable V6 region of the 16S rRNA gene
was amplified via PCR in two steps: the first step barcoded
the samples and the second added Illumina paired-end se-
quencing adapters [37]. The resulting PCR amplicons were
purified using the Qiagen 96-well purification kit (Qiagen,
CA), the amplicon concentration was determined using the
Quanti-It dsDNA BR assay (Invitrogen, UK), and 50 ng
from each reaction was pooled into a single tube. Pooled
DNA was run on a 1.5% agarose gel and visualized, and the
330-bp band was carefully cut out of the gel and purified
using a gel purification kit (Qiagen, CA). The final DNA
concentration was determined and the library sequenced
from both ends at The Centre for Applied Genomics at the
Hospital for Sick Children in Toronto, Canada, on the Illu-
mina HiSeq 2000 platform (100 base paired-end chemistry).
Appropriate positive and negative controls were run along-
side each library to confirm lack of contamination and ac-
curacy of the analysis pipeline.
Cell and tissue processing
Spleens were isolated aseptically and single-cell suspensions
made in complete media comprising Iscove’s Modified Eagle
Medium (IMDM) (Invitrogen) supplemented with 10%
heat-inactivated fetal bovine serum (FBS) and 100 U/mL
penicillin G and 100 μg/mL streptomycin. Single-cell sus-
pensions were achieved by passing the organs through a
40-μm nylon cell strainer (Becton Dickson, NJ) using a
2-mL syringe plunger. Cells were then spun at 1200 rpm for
5 min and media discarded, and the red blood cells lysed by
resuspending in 1 mL RBC lysis buffer (8.34 g ammonium
chloride, 0.037 g EDTA and 1 g sodium hydrogen carbon-
ate/L, pH 7.2) for 1 min. Cells were pelleted again and resus-
pended in complete media. Viability was determined by
trypan blue exclusion. Cells were then reconstituted to a
working concentration of 107 cells/mL and used for culture
and flow cytometry. Cells were plated in a 96-well plate and
stained for expression of extracellular markers.
Flow cytometry
Splenic lymphocytes were stained for surface markers as fol-
lows. For extracellular markers, single cells were stained at
2 × 106 cells per well in a 96-well V bottomed plate. T cells
were stained with anti-CD3 Alexa 700 (BD, clone 500A2),
anti-CD4 PerCP (BD, clone RM4-5), anti-CD44 FITC (BD,
clone IM7), anti-CD62L V450 (BD, clone MEL-14), and
anti-FOXP3 APC (BD, clone MF23). B cells were stained
with anti-CD19 PEcy7 (eBiosciences, clone 6D5), anti-B220
FITC (eBiosciences, clone RA3-6B2), anti-CD21 APC (BD,
clone 7G6), anti-CD23 PE (BD), and anti-CD80 V450 (BD,
clone 16-10A1). Fifty microliters of the antibody master mix
prepared in MACS buffer (1× PBS, 2 mM EDTA, and 0.5%
BSA) was added per well in all staining procedures. Cells
were acquired on an LSRII (Becton Dickinson) and analyzed
by FlowJo (Tree Star, Ashland).
Flow cytometry statistical analysis
Data was summarized using routine methods [38]. Stat-
istical analysis for mouse immunity data was performed
by GraphPad Prism version 6. Comparisons were made
by non-parametric analysis of variance followed by
Mann-Whitney U test. Data were considered statistically
significant if p < 0.05.
Antibody ELISAs
Breastmilk pellets were collected from pups’ stomach
2 weeks postpartum. Relative levels of IgG or IgM levels
were determined by antibody ELISA. Briefly, breastmilk
pellets were homogenized in 200 μl PBS. Samples were
then spun at 4000 rpm for 10 min and supernatants col-
lected. Protein concentrations were determined by BCA
assay and normalized to equal concentrations. Flat-bottomed
plates (Nunc, Maxisorp) were coated with 50 μl of IgG or
IgM capture antibody and incubated overnight at 4 °C. The
next day, plates were washed and blocked with 200 μl/well of
4% BSA in PBS for 3 h at 37 °C. After washing three times,
samples were added. Samples were diluted serially across six
wells starting with a dilution of 1.3. Plates were then incu-
bated overnight before being washed and the detector anti-
body (50 μl/well) added (Southern Biotech) for 3 h at 37 °C.
Plates were then washed and the signal was detected using
substrate p-nitrophenylphosphate powder at 1 mg/ml (Sig-
ma-Aldrich). Plates were incubated at 37 °C until the desired
coloration was obtained and read at a wavelength of 405 nm
using the Softmax Pro Program. Graphs were plotted as dilu-
tions versus optical densities.
Lipocalin-2 ELISA
Serum concentrations of lipocalin-2 were determined
using the Mouse Lipocalin-2/NGAL Quantikine ELISA
kit (R & D Systems, Minneapolis, MN). Samples were
diluted 1:100, and assay was performed according to the
manufacturer’s instructions. Samples were assayed in
duplicate.
Microbiome analysis
Sequence data was pre-processed in QIIME and UPARSE
[39, 40]. Briefly, sequences lacking barcodes were removed
and samples with less than 100,000 reads discarded. PCR
errors were removed by SeqNoise [41]. Primers and barcodes
were removed from de-noised sequences. Consequently,
de-noised sequences were clustered into operational
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taxonomic units (OTUs) at 97% sequence similarity. Taxo-
nomic assignment was done by RDP classifier using the
Greengenes database (version 13.8). The biom file was then
imported into Calypso or R for further downstream analysis.
Statistical analysis was done using Calypso version 6.4
using the default parameters [42]. Analyses were performed
by Kruskal-Wallis and Wilcoxon rank test and p values
adjusted for multiple comparisons by Benjamini-Hochberg
false discovery rate (FDR). Additional analyses were per-
formed in R, using the R packages phyloseq for beta diversity
analyses [43], vegan [44] for ordination and redundancy ana-
lysis, and randomForest [45] for predictive modeling. Statis-
tical testing was corrected for false discovery rate (FDR) by
Benjamini-Hochberg method, and adjusted p values less than
0.05 were considered statistically significant. Differences in
microbial composition between groups of interest were
assessed using metagenomeSeq’s MRfulltable function [44]
with a custom filter to determine significance: taxa were
deemed significantly different if they exhibited a fold change
(beta coefficient) of ≥ 1.25, if they had an adjusted p value of
≤ 0.05, and if at least one of the two groups being compared
had ≥ 20% of samples with the given OTU/taxa OR Fisher’s
exact test result was significant (after multiple testing correc-
tion using the Benjamini-Hochberg method). These results
were confirmed using the DESeq2 package [46]. To investi-
gate the contribution of maternal gut and breastmilk micro-
biota to the establishment of offspring gut microbiota, we
used a Bayesian approach for bacterial source tracking as has
been previously described [24]. Pup fecal samples were desig-
nated as sinks and maternal samples (gut and breastmilk) of
the corresponding mother selected as sources.
Additional file
Additional file 1: Figure S1. (A) Shannon α-diversity of maternal fecal
microbiota. (B) of maternal fecal microbial β-diversity based on Bray Curtis
distance. (C) Relative abundance at phyla level in dams. (D) PCoA of both pup
and dam stool microbiota in different cages. Results were combined from two
independent experiments. Related to Fig. 1. Figure S2.Maternal gut microbiota
and breast milk microbiota influence pup gut microbiota. Genital tract samples
were collected day 4 post delivery from dams (A) Principal coordinate analysis
by Bray-Curtis dissimilarity of genital tract microbiota. (B) Pie charts showing
representative pie charts of maternal source of bacteria in individual infant mice
gut. Data representative of two independent experiments. n= 4 genital tract
samples per group or 4–6 pups per group. *p< 0.05. Related to Fig. 2. Table S1.
Vancomycin levels in serum of dams and pups measured by the Abbott ELISA
technique. Levels across all groups were below the detection limit of 3 μg/ml.
Related to Fig. 1. (DOCX 773 kb)
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